Pharmacology Online Series

Series Overview 

Medication use among American adults is common, with 82% taking at least one medication and 29% taking five or more (Slone 2006). Medication safety is a significant concern. The Centers for Disease Control and Prevention predicts that adverse drug events (ADE), "harms resulting from the use of medication and include allergic reactions, side effects, overmedication, and errors" will rise. This is due to developing new medicines, discovering new uses for older medicines, an aging population, increasing the use of medicines for patient treatment and prevention of disease, and insurance coverage expansion for prescription medications (CDC, 2020). The IOM (2006) reported that $3.5 billion is spent due to ADEs annually and that over 40% of ADEs in ambulatory settings may be preventable.

The IOM (2006) recommends technological interventions, utilizing clinical pharmacists, medication-use processes, and non-technological interventions to prevent medication errors. Advance practice prescribers, pharmacists, and nurses having expertise in pharmacotherapeutics, roles and responsibilities, and interprofessional communication among the healthcare team is foundational to supporting these recommendations.

Elements of Competence

This Continuing Education activity is designed to change learner knowledge and competence, focusing on the American Board of Medical Specialties area of medical knowledge, Institute of Medicine areas of patient-centered care, working in interdisciplinary teams and evidence-based medicine, Center for the Advancement of Pharmacy Education areas of communication, interprofessional collaboration, and medication use, and the Interprofessional and Nursing areas of roles/responsibilities and interprofessional communication. 

Target Audience

This activity is designed for advance practice providers, pharmacists, nurses, and other prescribers working in all healthcare settings.

Learning Objectives

As a result of this educational activity learners will be able to:
  1. Describe clinical use(s), mechanism(s) of action, and therapeutic and adverse effects of pharmacotherapeutics
  2. Translate pharmacological principles and apply them in your practice
  3. Examine the intersection of pharmacotherapeutics, communication, roles and roles and responsibilities among the healthcare team and potential impact on patient outcomes
  4. Discuss how interprofessional communication and pharmacotherapeutics is integrated within current National Patient Safety Goals and Joint Commission Standards 
Course summary
Available credit: 
  • 2.50 ANCC Contact Hours
  • 2.50 Iowa Board of Nursing Contact Hours
  • 2.50 University of Wisconsin–Madison Continuing Education Hours
Registration opens: 
07/01/2020
Course expires: 
07/31/2023
Cost:
$0.00
Rating: 
0

 

PLANNING COMMITTEE 

Sue Gaard, MS, RN
University of Wisconsin–Madison, School of Nursing
Paul Hutson, PharmD, MS
University of Wisconsin–Madison, School of Pharmacy
Kristen Panther, NP
UW Health, Department of Medicine
Eric Buxton, PhD, BS
University of Wisconsin–Madison, School of Pharmacy
Krista Morin, PA-C
UW Health, BerbeeWalsch Department of Emergency Medicine
Diane Reinfeldt, DNP, RN, CNE
University of Wisconsin–Madison, School of Nursing
Allison Henke, BSN, RN
UW Health, Regional Services
Tracy Mrochek, MPA, RN
University of Wisconsin–Madison, School of Nursing
 

POLICY ON DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity materials.

Disclosures will be available prior to the start of the conference.

*The ACCME, ACPE, and ANCC defines a commercial interest as any entity producing, marketing, re‐selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME, ACPE, and ANCC does not consider providers of clinical service directly to patients to be commercial interests.

The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact info@icep.wisc.edu.

Discloser List CME Internal Report

 

Accreditation Statement

In support of improving patient care, the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation Statements

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates the enduring program (recorded sessions) for a maximum of ANCC contact hours and the live activity (in-person training) for a maximum of 8.00 ANCC contact hours.  

The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing Provider 350. Iowa Board of Nursing accepts ANCC contact hours for nursing continuing education requirements.

AAPA Credit Designation Statement

The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This enduring program is designated for X AAPA Category 1 CME credits.PAs should only claim credit commensurate with the extent of their participation

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this enduring program for a maximum of X AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Education Units (CEUs)

The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this enduring program (recorded sessions) for continuing education units (CEUs) or hours.

Accreditation Council for Pharmacy Education (ACPE)

A maximum of X hour of knowledge-based CE credit can be earned by successfully completing this enduring activity. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance, will be provided to NABP within 60 days after the activity completion.

2020 Universal Activity Number (UAN)JA0000358-0000-20-038-L04-P

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for X CEUs or X hours. 

 

Available Credit

  • 2.50 ANCC Contact Hours
  • 2.50 Iowa Board of Nursing Contact Hours
  • 2.50 University of Wisconsin–Madison Continuing Education Hours
 
Status
Price
Title
$0.00Included
Please login or register to take this course.

Price

Cost:
$0.00
Please login or register to take this course.

QUESTIONS ABOUT REGISTRATION

Email ceservices@son.wisc.edu or call 608-262-8017.